| Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress R Tao, MC Coleman, JD Pennington, O Ozden, SH Park, H Jiang, HS Kim, ... Molecular cell 40 (6), 893-904, 2010 | 987 | 2010 |
| SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress HS Kim, K Patel, K Muldoon-Jacobs, KS Bisht, N Aykin-Burns, ... Cancer cell 17 (1), 41-52, 2010 | 901 | 2010 |
| SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression KM Jacobs, JD Pennington, KS Bisht, N Aykin-Burns, HS Kim, M Mishra, ... Int J Biol Sci 4 (5), 291-299, 2008 | 304 | 2008 |
| SIRT3 deacetylates ATP synthase F1 complex proteins in response to nutrient-and exercise-induced stress A Vassilopoulos, JD Pennington, T Andresson, DM Rees, AD Bosley, ... Antioxidants & redox signaling 21 (4), 551-564, 2014 | 198 | 2014 |
| Sirt3, mitochondrial ROS, ageing, and carcinogenesis SH Park, O Ozden, H Jiang, YI Cha, JD Pennington, N Aykin-Burns, ... International journal of molecular sciences 12 (9), 6226-6239, 2011 | 130 | 2011 |
| Redox-sensitive signaling factors as a novel molecular targets for cancer therapy JD Pennington, TJC Wang, P Nguyen, L Sun, K Bisht, DD Smart, D Gius Drug resistance updates 8 (5), 322-330, 2005 | 99 | 2005 |
| Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy JD Pennington, KM Jacobs, L Sun, G Bar-Sela, M Mishra, D Gius Current pharmaceutical design 13 (33), 3368-3377, 2007 | 77 | 2007 |
| A search for amino acid substitutions that universally activate response regulators JG Smith, JA Latiolais, GP Guanga, JD Pennington, RE Silversmith, ... Molecular microbiology 51 (3), 887-901, 2004 | 67 | 2004 |
| DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells MV Mishra, KS Bisht, L Sun, K Muldoon-Jacobs, R Awwad, A Kaushal, ... Molecular Cancer Research 6 (2), 243-249, 2008 | 54 | 2008 |
| Long-term outcomes with ifosfamide-based hypofractionated preoperative chemoradiotherapy for extremity soft tissue sarcomas JD Pennington, FC Eilber, FR Eilber, AS Singh, JP Reed, B Chmielowski, ... American journal of clinical oncology 41 (12), 1154-1161, 2018 | 38 | 2018 |
| Distinct effects of ionizing radiation on in vivo murine kidney and brain normal tissue gene expression W Zhao, EY Chuang, M Mishra, R Awwad, K Bisht, L Sun, P Nguyen, ... Clinical cancer research 12 (12), 3823-3830, 2006 | 37 | 2006 |
| Dosimetric comparison of brachyablation and stereotactic ablative body radiotherapy in the treatment of liver metastasis JD Pennington, SJ Park, N Abgaryan, R Banerjee, PP Lee, C Loh, E Lee, ... Brachytherapy 14 (4), 537-542, 2015 | 20 | 2015 |
| Visualizing early frog development with motion-sensitive 3-D optical coherence microscopy RC Haskell, ME Williams, DC Petersen, BM Hoeling, AJ Schile, ... The 26th Annual International Conference of the IEEE Engineering in Medicine …, 2004 | 5 | 2004 |
| Cryoamputation as a Temporizing Measure in Severe Burn Injury JD Pennington, AE Wall, JJ Schlesinger, KK Higdon, L Weavind Journal of Burn Care & Research 35 (4), e273-e275, 2014 | 4 | 2014 |
| Simulated consult and treatment exercise improves radiation oncology trainee confidence and knowledge LF Valle, P Kundu, SM Yoon, JD Pennington, M Cao, PP Lee, AU Kishan Journal of Education and Health Promotion 10 (1), 218, 2021 | 1 | 2021 |
| Comment on “Medical use of all high activity sources should be eliminated for security concerns”[Med. Phys. 42, 6773–6775 (2015)] JD Pennington, SJ Park, PP Lee, DJ Demanes Medical Physics 43 (7), 4459-4460, 2016 | 1 | 2016 |
| 66 A SIRT3/FOXO3a/MnSOD signaling model for mitochondrial superoxide levels JD Pennington, KM Jacobs, MV Mishra, P Nguyen, D Gius Mitochondrion 6 (7), 423, 2007 | 1 | 2007 |
| Employment characteristics and work ability differences by race and income before undergoing curative treatment for prostate cancer (PCW WF-1802) JC Sandberg, EV Dressler, LS Krane, KM Winkfield, L Lu, AM Mayfield, ... Cancer Research 84 (6_Supplement), 805-805, 2024 | | 2024 |
| The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer in NRG/RTOG 1016 JB Weidhaas, J Harris, M Gillison, DM Blakaj, GA Krempl, KA Higgins, ... International Journal of Radiation Oncology, Biology, Physics 117 (2), S151, 2023 | | 2023 |
| Racial Disparities in Prostate Cancer–Specific Survival After Definitive Treatment for Gleason 8-10 Localized Prostate Cancer C Wang, J Wang, JDD Pennington, PA Kupelian, ML Steinberg, ... International Journal of Radiation Oncology• Biology• Physics 96 (2), E247, 2016 | | 2016 |
